Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bydureon BCise 2mg/0.85ml prolonged-release inj pf pens
0601023Y0BCACAE
|
Bydureon | Exenatide | Endocrine System | 6,424 |
|
Exenatide 10micrograms/0.04ml inj 2.4ml pf dispos dev
0601023Y0AAABAB
|
Exenatide | Exenatide | Endocrine System | 3,263 |
|
Exenatide 2mg/0.85ml prolonged-release inj pf dispos dev
0601023Y0AAAEAE
|
Exenatide | Exenatide | Endocrine System | 3,030 |
|
Bydureon 2mg inj pre-filled pens
0601023Y0BCABAD
|
Bydureon | Exenatide | Endocrine System | 2,170 |
|
Exenatide 2mg inj pre-filled disposable devices
0601023Y0AAADAD
|
Exenatide | Exenatide | Endocrine System | 1,898 |
|
Exenatide 5micrograms/0.02ml inj 1.2ml pf dispos dev
0601023Y0AAAAAA
|
Exenatide | Exenatide | Endocrine System | 752 |
|
Byetta 10micrograms/0.04ml inj 2.4ml pre-filled pens
0601023Y0BBABAB
|
Byetta | Exenatide | Endocrine System | 693 |
|
Byetta 5micrograms/0.02ml inj 1.2ml pre-filled pens
0601023Y0BBAAAA
|
Byetta | Exenatide | Endocrine System | 99 |
|
Bydureon 2mg inj vials
0601023Y0BCAAAC
|
Bydureon | Exenatide | Endocrine System | 10 |
|
Exenatide 2mg inj vials
0601023Y0AAACAC
|
Exenatide | Exenatide | Endocrine System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.